Gallacher Capital Management LLC Has $610,000 Position in HCA Healthcare, Inc. (NYSE:HCA)

Gallacher Capital Management LLC decreased its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 3.9% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 2,253 shares of the company’s stock after selling 92 shares during the period. Gallacher Capital Management LLC’s holdings in HCA Healthcare were worth $610,000 at the end of the most recent quarter.

A number of other hedge funds have also recently bought and sold shares of HCA. Stone House Investment Management LLC bought a new position in HCA Healthcare in the 3rd quarter valued at $25,000. BluePath Capital Management LLC bought a new stake in HCA Healthcare in the third quarter worth about $27,000. Centerpoint Advisors LLC purchased a new stake in shares of HCA Healthcare during the 4th quarter worth approximately $27,000. Bruce G. Allen Investments LLC purchased a new position in HCA Healthcare in the fourth quarter valued at approximately $28,000. Finally, Annis Gardner Whiting Capital Advisors LLC bought a new stake in shares of HCA Healthcare in the third quarter valued at $30,000. 62.73% of the stock is owned by hedge funds and other institutional investors.

HCA Healthcare Trading Down 0.3 %

HCA Healthcare stock traded down $1.08 during midday trading on Friday, reaching $307.76. The stock had a trading volume of 1,044,934 shares, compared to its average volume of 1,189,320. The firm has a market cap of $81.40 billion, a price-to-earnings ratio of 15.34, a price-to-earnings-growth ratio of 1.44 and a beta of 1.66. The company has a fifty day moving average of $322.22 and a 200 day moving average of $298.18. HCA Healthcare, Inc. has a 52-week low of $215.96 and a 52-week high of $335.83. The company has a quick ratio of 1.02, a current ratio of 1.16 and a debt-to-equity ratio of 29.26.

HCA Healthcare (NYSE:HCA) last released its earnings results on Friday, April 26th. The company reported $5.36 earnings per share for the quarter, topping analysts’ consensus estimates of $5.01 by $0.35. The business had revenue of $17.34 billion for the quarter, compared to analyst estimates of $16.81 billion. HCA Healthcare had a return on equity of 674.49% and a net margin of 8.20%. The business’s revenue was up 11.2% compared to the same quarter last year. During the same quarter last year, the firm posted $4.93 earnings per share. On average, analysts anticipate that HCA Healthcare, Inc. will post 20.74 earnings per share for the current fiscal year.

HCA Healthcare declared that its Board of Directors has authorized a stock repurchase plan on Tuesday, January 30th that authorizes the company to buyback $6.00 billion in shares. This buyback authorization authorizes the company to purchase up to 7.4% of its stock through open market purchases. Stock buyback plans are typically an indication that the company’s management believes its shares are undervalued.

HCA Healthcare Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, June 28th. Stockholders of record on Friday, June 14th will be given a $0.66 dividend. The ex-dividend date is Friday, June 14th. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.86%. HCA Healthcare’s payout ratio is 13.16%.

Insider Buying and Selling at HCA Healthcare

In other news, SVP Sammie S. Mosier sold 1,645 shares of HCA Healthcare stock in a transaction on Monday, February 5th. The shares were sold at an average price of $312.00, for a total transaction of $513,240.00. Following the completion of the sale, the senior vice president now directly owns 7,646 shares in the company, valued at $2,385,552. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. In related news, SVP Sammie S. Mosier sold 1,645 shares of HCA Healthcare stock in a transaction dated Monday, February 5th. The stock was sold at an average price of $312.00, for a total transaction of $513,240.00. Following the completion of the sale, the senior vice president now owns 7,646 shares of the company’s stock, valued at $2,385,552. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Chad J. Wasserman sold 876 shares of the firm’s stock in a transaction that occurred on Wednesday, March 20th. The stock was sold at an average price of $330.25, for a total transaction of $289,299.00. Following the transaction, the senior vice president now directly owns 1,576 shares of the company’s stock, valued at $520,474. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 7,127 shares of company stock worth $2,218,364. 1.60% of the stock is owned by insiders.

Analyst Ratings Changes

A number of equities research analysts recently issued reports on HCA shares. Deutsche Bank Aktiengesellschaft boosted their price objective on HCA Healthcare from $330.00 to $359.00 and gave the company a “buy” rating in a research note on Friday, April 12th. Wells Fargo & Company lifted their price objective on shares of HCA Healthcare from $303.00 to $315.00 and gave the company an “equal weight” rating in a research note on Thursday, March 28th. TD Cowen cut their price target on HCA Healthcare from $371.00 to $360.00 and set a “buy” rating for the company in a report on Tuesday, April 30th. Oppenheimer raised their price target on shares of HCA Healthcare from $330.00 to $345.00 and gave the company an “outperform” rating in a report on Monday, April 29th. Finally, Truist Financial boosted their target price on HCA Healthcare from $320.00 to $345.00 and gave the stock a “buy” rating in a research report on Wednesday, January 31st. Four analysts have rated the stock with a hold rating, twelve have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $316.59.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.